GEA and Hovione have strengthened their longstanding partnership to deliver new levels of flexibility and simplicity in continuous tableting. This enhanced collaboration has led to the development of the ConsiGma® CDC Flex system, a next-generation platform that makes continuous direct compression (CDC) more flexible, efficient, and cost-effective.
The freeze-drying process is usually associated with high energy consumption. With the LYOVAC®ECO mode, GEA optimizes the energy consumption of pharmaceutical freeze-drying systems. Validations and comparisons with previous solutions and models and international standards have shown a possible reduction in power consumption of around 20 percent. The LYOVAC®ECO mode has now been awarded the "Add Better" environmental label on the basis of demonstrable resource conservation and a stringent evaluation process developed by GEA in collaboration with TÜV Rheinland. For customers, the traceable test process means maximum transparency.
Now manufactured in India, the PERFORMA D reinforces GEA’s strategy to localize key technologies and enhance service capability for pharmaceutical manufacturers across India and South Asia.
GEA is investing EUR 80 million in the construction of a pharmaceutical technology center for freeze-drying systems in Elsdorf (North Rhine-Westphalia). Partial approval was granted by the authorities in July 2025. With the new location, GEA is responding to the growing global demand for freeze-drying systems while creating capacity for further growth and technological innovation. The relocation of the previous operations in Hürth to Elsdorf has now begun. Shortly after the partial handover, the first product chambers, central components for the production of freeze dryers in which the actual drying process takes place, were delivered. The installation of the first freeze dryers at the new location represents an important milestone in the construction of GEA's new pharmaceutical technology center.
GEA, one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries, has further improved the planet friendly operation of equipment designed for the large-scale production of oral solid dosage forms. According to defined criteria from TÜV Rheinland — a leading testing service provider — the NexGen Press® 45 has been externally audited to qualify for two of GEA’s recently introduced “Add Better” labels. GEA thus helps pharmaceutical manufacturing companies to comply with the stringent requirements of ISO 14021.
GEA introduces the kytero® 10, the world's smallest single use disk stack centrifuge. This mini centrifuge is used in the biopharmaceutical, food and new food industries for product development, which can often only provide small bioreactor sizes.
GEA and its partners are leading the way toward smaller, more flexible continuous processing technologies.
GEA, one of the world's largest suppliers of systems and components for the food, beverage and pharmaceutical industries, has made important adjustments to take pharmaceutical freeze-drying to an even higher level of sustainability. At ACHEMA 2024 in Frankfurt/Main, GEA presented the latest developments in the freeze-drying technology, which helps to optimize production processes, reduce environmental impact and save energy.
GEA is a pioneer in cell separation and recycling in biopharmaceutical perfusion processes. For the first time, perfusion disc separators for continuous production and faster processing can be implemented in biopharma cell harvesting processes based on labour-saving, easy-to-use single-use devices.
GEA Pharma & Healthcare has now introduced the latest member of the NexGen Press® family. As a reliable supplier of state-of-the-art tableting equipment, the NexGen Press® range represents the future of tablet compression for the pharmaceutical industry. The experts at GEA have combined the best aspects of their existing equipment to create a family of machines that represent the next generation of tablet compression.
Hovione, the specialist integrated CDMO and leader in spray drying and particle engineering, and GEA, a global leader in process technology for the pharmaceutical industry, today announced the next stage of their partnership, with new development agreements, the launch of the ConsiGma® CDC flex as well as the installation of a new lab-scale R&D Continuous Tableting rig in Hovione´s facilities in Portugal.